Sign in
Taking people in United KingdomNo phase

Moving From Baha Connect to Osia Implants for Hearing Loss

Tests Osia in Baha users with conductive or mixed hearing loss.

Key facts

Who runs it
Cochlear
Where
London, Nottingham, and Sheffield, United KingdomSee the 3 sites
Trial code
Registry title
Post-market Evaluation of the Transition From the Baha Connect System to the Osia System in Adult Bone Conduction Implant Recipients
Status
Recruiting
People taking part
20 people, planned
Started
24 Jul 2026
Expected to end
Dec 2028
Type of study
Interventional
Treatments tested
  • Cochlear™ Osia® System
  • Cochlear™ Baha® System
Record updated
2 September 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with mixed or conductive hearing loss who already use a Baha Connect implant and are moving to the Osia System.

Age
18 years or older
Sex
All sexes
Disease stage
Mixed or conductive hearing loss in the ear with the Baha Connect System. Bone conduction hearing level (PTA4) of ≤ 55 dB HL in that ear.
Earlier treatment
Must have a Cochlear Baha BI300 Implant with a Baha BA300 Abutment (Baha Connect), used for at least 6 months. The study doctor must judge the person unhappy with it for medical reasons, such as repeated skin reactions.

Main reasons for not taking part

  • Hearing loss in one ear only, with the other ear hearing at ≤ 20 dB HL
  • Acute infection (Holgers grade 4) at the implant site at screening
  • Taking part in another study of a test drug or device in the past 30 days
  • Study staff, their close family, or Cochlear employees and contractors
  • Not able or willing to follow the study requirements

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • 18 years of age or older
  • Implanted with a Cochlear Baha BI300 Implant in combination with a Cochlear Baha BA300 Abutment (Baha Connect)
  • Mixed or conductive hearing loss in the ear implanted with the Baha Connect System
  • Bone conduction thresholds with pure tone average (PTA4; mean of 0.5, 1, 2, and 4 kHz) of ≤ 55 dB HL in the ear implanted with the Baha Connect System
  • Experience of at least 6 months with the Baha Connect System
  • Candidate is judged by the investigator to be dissatisfied with their current Baha Connect System due to medical issues, e.g., recurrent adverse skin reactions, and is considered likely to benefit from transitioning to an Osia System
  • Candidate is a fluent speaker in the language used to assess speech perception performance
  • Candidate is willing and able to provide written informed consent
  • Candidate has a retrospective medical record from the time of implantation with the Baha Connect System which the investigational site is authorized to review

Who cannot take part

  • Current participation, or participation in another interventional clinical study/trial in the past 30 days, involving an investigational drug or device (unless Cochlear sponsored and determined by the investigator or Sponsor to not impact this investigation)
  • Candidate with an acute infection (Holgers grade 4) at the implant site at the time of screening
  • Candidate with single-sided deafness (air conduction thresholds with pure tone average (PTA4; mean of 0.5, 1, 2 and 3 kHz) of ≤ 20 dB HL in the good ear)
  • Unable or unwilling to comply with the requirements of the clinical investigation as determined by the Investigator
  • Investigator site personnel directly affiliated with this study and/or their immediate families; immediate family is defined as a spouse, parent, child, or sibling
  • Cochlear employees or employees of Contract Research Organizations or contractors engaged by Cochlear for the purposes of this investigation

Where in United Kingdom

  • Royal National Ear, Nose and Throat and Eastman Dental HospitalsLondon, United KingdomContact: PRS SpecialistTaking people
  • Nottingham Auditory Implant ProgrammeNottingham, United KingdomContact: PRS SpecialistNot yet recruiting
  • Sheffield Teaching HospitalsSheffield, United KingdomContact: PRS SpecialistTaking people

About the trial

What the trial wants to find out

The goal of this interventional study is to confirm the safety and performance of the latest generation Osia System and to examine its benefits compared to the Baha Connect System in adults with mixed or conductive hearing loss who have a pre-existing Baha implant and Abutment (BIA300) and are transitioning to the Osia System.

Read full original descriptionShow less

The main questions this study aims to answer are:

* Is the safety and performance of the Osia System confirmed by study findings? * What are the benefits of the Osia System compared to the Baha Connect System?

Participants will:

* Undergo speech performance testing in both quiet and noisy environments * Provide ratings for various questionnaires

The group in the trial

  • Cochlear™ Osia® System and Cochlear™ Baha® SystemTreatment being tested

    Participants undergoing transition from the Baha Connect System to the Osia System will complete a series of assessments and questionnaires designed to evaluate the clinical performance and user satisfaction of both systems.

    Treatment: Cochlear™ Osia® System and Cochlear™ Baha® System

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Post-Market Clinical Follow-Up of the Osia System and Evaluation of Benefits of Transitioning From the Baha Connect System to the Osia System in Adult Bone Conduction Implant Recipients With Mixed or Conductive Hearing Loss
Plain-language title
Moving From Baha Connect to Osia Implants for Hearing LossGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
2 September 2026